Cargando...
A high-throughput screening assay for eukaryotic elongation factor 2 kinase inhibitors
Eukaryotic elongation factor 2 kinase (eEF2K) inhibitors may aid in the development of new therapeutic agents to combat cancer. Purified human eEF2K was obtained from an Escherichia coli expression system and a luminescence-based high-throughput screening (HTS) assay was developed using MH-1 peptide...
Gardado en:
| Publicado en: | Acta Pharm Sin B |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5071636/ https://ncbi.nlm.nih.gov/pubmed/27818922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2016.04.002 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|